First Trust Developed Markets ex-US Small Cap AlphaDEX Fund (FDTS)
Live price chart, market sentiment, and community perspectives for First Trust Developed Markets ex-US Small Cap AlphaDEX Fund (NASDAQ: FDTS).
Live price chart, market sentiment, and community perspectives for First Trust Developed Markets ex-US Small Cap AlphaDEX Fund (NASDAQ: FDTS).
Evaluating the underlying constituents from a fundamental research angle, foreign small caps often lack the robust sell-side coverage found in large-cap equities. This information asymmetry is precisely what the AlphaDEX methodology attempts to exploit through fundamental scoring metrics like book value, cash flow, and return on assets.
As a Risk Manager, my primary concern with FDTS is unhedged currency exposure paired with small-cap beta. When developed market currencies fluctuate against the US dollar, the portfolio experiences localized volatility that can overshadow the underlying fundamental performance of the portfolio holdings.
Looking at the structural asset management landscape, ETFs employing proprietary quantitative screening like AlphaDEX must continuously prove their factor efficacy across varied macroeconomic cycles. International small caps are notoriously sensitive to global economic slowdowns and domestic credit tightening abroad.
On our options desk, liquidity on international equity ETFs like FDTS tends to be thinner compared to large-cap counterparts, impacting how we structure tail hedges. Implied volatility can occasionally misprice the underlying structural liquidity risk of small-cap foreign baskets, creating tactical opportunities for structured overlay strategies.
From a quantitative perspective, the multi-factor selection model utilized by FDTS creates dynamic sector rotations that differ significantly from market-cap-weighted benchmarks. We track the factor turnover closely to ensure that the alpha generation persists after accounting for rebalancing friction and underlying tracking error relative to broader EAFE small-cap indexes.
Explore plasma cleansing, somatic organ swaps, and BCI.